Today's Top Stories | | By Sam Quirke | February 12, 2026 08:34 AM |
| | | By Jeffrey Neal Johnson | February 12, 2026 07:30 AM |
| | By Jeffrey Neal Johnson | February 12, 2026 06:17 AM |
| | | By Thomas Hughes | February 11, 2026 05:41 PM |
| | By Jordan Chussler | February 10, 2026 10:19 AM |
|
|
 | Stock market "omen" points to historic buying opportunity? (ad)Are we about to witness another Great Recession? One Wall Street legend is making a bold claim. After helping his clients avoid financial ruin in 2008 by telling them to look out below right before stocks tanked by 50%, he's coming forward with a surprising new prediction. Before the next major crash truly begins, you still have months to potentially profit from stocks. But he says this could be the market's last gasp before it all comes down, and it could be years before it recovers. Right now could be your last chance to profit in the stock market before you could see the value of your portfolio cut in half once again. See the full prediction and how to potentially profit |
|
Analysts' Upgrades | | Analog Devices (NASDAQ:ADI) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $375.00 price target on the stock. This represents a 9.6% upside from the current price of $342.02. | | EuroDry (NASDAQ:EDRY) was upgraded by analysts at Noble Financial from a "market perform" rating to an "outperform" rating. They now have a $23.50 price target on the stock. This represents a 65.3% upside from the current price of $14.22. | | Huntington Ingalls Industries (NYSE:HII) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $400.00 price target on the stock. This represents a 1.0% downside from the current price of $404.13. | | Hexcel (NYSE:HXL) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $95.00 price target on the stock. This represents a 2.9% upside from the current price of $92.32. | | LuxExperience B.V. (NYSE:LUXE) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $14.00 price target on the stock, up previously from $9.00. This represents a 34.9% upside from the current price of $10.38. | | MercadoLibre (NASDAQ:MELI) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $2,800.00 price target on the stock, up previously from $2,650.00. This represents a 33.7% upside from the current price of $2,094.48. | | Old Dominion Freight Line (NASDAQ:ODFL) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $220.00 price target on the stock. This represents a 12.4% upside from the current price of $195.80. |
| View More Upgrades
|
Analysts' Downgrades | | Arcellx (NASDAQ:ACLX) was downgraded by analysts at Rothschild & Co Redburn from a "buy" rating to a "neutral" rating. They now have a $82.00 price target on the stock. This represents a 19.6% upside from the current price of $68.55. | | Coinbase Global (NASDAQ:COIN) was downgraded by analysts at Monness Crespi & Hardt from a "buy" rating to a "neutral" rating. They now have a $120.00 price target on the stock. This represents a 18.3% downside from the current price of $146.92. | | Great Lakes Dredge & Dock (NASDAQ:GLDD) was downgraded by analysts at Noble Financial from an "outperform" rating to a "market perform" rating.The current price is $16.93. | | Kraft Heinz (NASDAQ:KHC) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $22.00 price target on the stock. This represents a 9.4% downside from the current price of $24.28. | | Legend Biotech (NASDAQ:LEGN) was downgraded by analysts at Rothschild & Co Redburn from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock. This represents a 31.5% upside from the current price of $18.26. | | Pfizer (NYSE:PFE) was downgraded by analysts at Daiwa Securities Group Inc. from an "outperform" rating to a "neutral" rating. They now have a $27.00 price target on the stock. This represents a 2.0% downside from the current price of $27.55. | | Sanofi (NASDAQ:SNY) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating.The current price is $47.63. | | Valvoline (NYSE:VVV) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $35.00 price target on the stock, up previously from $30.00. This represents a 10.9% downside from the current price of $39.30. |
| View More Downgrades
|
 | The AI Arms Race Has a New Contender: VWAV (ad)With 50+ patents, live pilots across four countries, and a new advisory board stacked with military and diplomatic heavyweights, VisionWave Holdings (NASDAQ: VWAV) is positioning itself at the center of the global shift toward autonomous defense intelligence. The company's proprietary Vision-RF and Evolved Intelligence platforms are built for autonomous sensing, high-precision radar intelligence, and battlefield-ready AI decision support. Early-stage deployments include a $216,000 live-fire evaluation with a UAE defense prime, U.S. Army C-UAS submissions, Israeli border security tests, and a 10-year collaboration framework in India. With the global defense radar market expected to nearly double by 2034 and VWAV carrying a debt-free balance sheet, the company is targeting a revenue inflection point as military customers move from testing to adoption in 2026. See Why VWAV Is Drawing Attention in Defense-AI Circles |
|
Analysts' New Coverage | | Adherex Technologies (NASDAQ:FENC) is now covered by analysts at B. Riley Securities. They set a "buy" rating and a $16.00 price target on the stock. This represents a 89.6% upside from the current price of $8.44. | | Honda Motor (NYSE:HMC) is now covered by analysts at BNP Paribas Exane. They set an "underperform" rating and a $25.00 price target on the stock. This represents a 21.5% downside from the current price of $31.83. | | Microchip Technology (NASDAQ:MCHP) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $80.00 price target on the stock. This represents a 2.6% downside from the current price of $82.16. | | Sezzle (NASDAQ:SEZL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $85.00 price target on the stock. This represents a 39.6% upside from the current price of $60.91. | | USA Today (NYSE:TDAY) is now covered by analysts at Rosenblatt Securities. They set a "buy" rating and a $10.00 price target on the stock. This represents a 62.1% upside from the current price of $6.17. | | Toyota Motor (NYSE:TM) is now covered by analysts at BNP Paribas Exane. They set an "outperform" rating and a $290.00 price target on the stock. This represents a 19.2% upside from the current price of $243.19. | | Ermenegildo Zegna (NYSE:ZGN) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $11.00 price target on the stock. This represents a 0.7% upside from the current price of $10.93. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
No comments:
Post a Comment